US Stock MarketDetailed Quotes

ResMed (RMD)

Watchlist
  • 228.870
  • +0.890+0.39%
Close Apr 10 16:00 ET
  • 228.870
  • 0.0000.00%
Post 20:01 ET
33.34BMarket Cap22.64P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ResMed (RMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
10.98%1.42B
9.07%1.34B
9.84%5.15B
10.20%1.35B
7.92%1.29B
10.26%1.28B
11.08%1.22B
10.95%4.69B
9.01%1.22B
7.17%1.2B
Operating revenue
10.98%1.42B
9.07%1.34B
9.84%5.15B
10.20%1.35B
7.92%1.29B
10.26%1.28B
11.08%1.22B
10.95%4.69B
9.01%1.22B
7.17%1.2B
Cost of revenue
2.50%544.08M
1.47%514.76M
3.02%2.09B
3.99%527.93M
4.19%525.33M
2.90%530.81M
1.00%507.29M
8.71%2.03B
0.59%507.67M
1.01%504.2M
Gross profit
16.96%878.72M
14.44%820.82M
15.05%3.05B
14.61%820.07M
10.63%766.41M
16.13%751.28M
19.52%717.22M
12.72%2.66B
15.90%715.53M
12.15%692.78M
Operating expense
14.10%381.13M
8.66%358.47M
7.58%1.37B
8.73%363.5M
6.90%340.14M
8.59%334.03M
6.06%329.91M
5.61%1.27B
0.95%334.31M
0.35%318.2M
Selling and administrative expenses
15.22%278.4M
8.46%259.19M
8.06%991.02M
9.47%265.13M
6.69%245.3M
8.76%241.61M
7.23%238.98M
4.94%917.14M
0.62%242.19M
0.64%229.92M
Research and development costs
11.79%90.97M
9.81%87.32M
7.73%331.28M
6.90%86.44M
8.91%83.94M
10.14%81.37M
5.04%79.52M
6.91%307.53M
3.48%80.86M
0.83%77.07M
Depreciation amortization depletion
6.49%11.76M
4.84%11.96M
-2.68%45.27M
5.91%11.93M
-2.76%10.9M
-4.58%11.05M
-8.61%11.4M
10.71%46.52M
-8.58%11.26M
-8.07%11.2M
-Depreciation and amortization
6.49%11.76M
4.84%11.96M
-2.68%45.27M
5.91%11.93M
-2.76%10.9M
-4.58%11.05M
-8.61%11.4M
10.71%46.52M
-8.58%11.26M
-8.07%11.2M
Operating profit
19.26%497.6M
19.37%462.35M
21.91%1.69B
19.77%456.57M
13.80%426.27M
22.96%417.24M
34.02%387.31M
20.15%1.38B
33.18%381.22M
24.58%374.58M
Net non-operating interest income expense
1,125.68%7.95M
629.38%8.79M
109.00%4.11M
197.23%5.76M
107.19%793K
94.39%-775K
88.89%-1.66M
3.53%-45.71M
60.38%-5.92M
26.32%-11.03M
Non-operating interest expense
----
----
----
----
----
----
----
-3.53%45.71M
----
----
Total other finance cost
-1,125.68%-7.95M
-629.38%-8.79M
-109.00%-4.11M
-197.23%-5.76M
-107.19%-793K
-94.39%775K
-88.89%1.66M
-3.53%45.71M
-60.38%5.92M
-26.32%11.03M
Other net income (expense)
-606.80%-9.4M
-1,030.32%-24.35M
81.06%-13.94M
75.66%-4.28M
-178.97%-9.37M
102.81%1.85M
-16.50%-2.15M
-2,392.04%-73.62M
-418.92%-17.56M
223.15%11.86M
Earnings from equity interest
603.04%1.82M
-1,761.13%-4.7M
-12.93%-6.66M
91.34%-1.27M
-136.99%-5.31M
68.49%-362K
106.29%283K
-321.79%-5.89M
-283.16%-14.61M
130.30%14.36M
Special income (charges)
---5.94M
---15.81M
96.84%-2.03M
---2.03M
--0
--0
--0
-63,692.08%-64.23M
--0
--0
-Less：Restructuring and merger&acquisition
--5.94M
--15.81M
-96.84%2.03M
--2.03M
--0
--0
--0
219.13%64.23M
--0
--0
Other non- operating income (expenses)
-338.36%-5.28M
-57.41%-3.84M
-50.43%-5.26M
66.89%-979K
-62.50%-4.06M
423.03%2.22M
-192.03%-2.44M
38.83%-3.49M
-4,947.54%-2.96M
2.65%-2.5M
Income before tax
18.60%496.15M
16.50%446.79M
32.64%1.68B
28.04%458.05M
11.26%417.69M
61.23%418.32M
40.89%383.5M
14.81%1.26B
29.24%357.73M
29.73%375.42M
Income tax
40.51%103.56M
36.20%98.26M
13.53%276.84M
19.62%78.35M
-29.73%52.65M
45.50%73.7M
36.71%72.14M
19.47%243.85M
38.95%65.5M
31.74%74.93M
Net income
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
Net income continuous Operations
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
Minority interest income
Net income attributable to the parent company
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.92%392.59M
11.94%348.54M
37.20%1.4B
29.93%379.71M
21.48%365.04M
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
Basic earnings per share
14.47%2.69
12.26%2.38
37.61%9.55
30.15%2.59
22.06%2.49
65.49%2.35
42.28%2.12
13.40%6.94
27.56%1.99
29.11%2.04
Diluted earnings per share
14.53%2.68
12.32%2.37
37.43%9.51
30.30%2.58
21.57%2.48
64.79%2.34
41.61%2.11
13.63%6.92
26.92%1.98
29.11%2.04
Dividend per share
13.21%0.6
13.21%0.6
10.42%2.12
10.42%0.53
10.42%0.53
10.42%0.53
10.42%0.53
9.09%1.92
9.09%0.48
9.09%0.48
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 10.98%1.42B9.07%1.34B9.84%5.15B10.20%1.35B7.92%1.29B10.26%1.28B11.08%1.22B10.95%4.69B9.01%1.22B7.17%1.2B
Operating revenue 10.98%1.42B9.07%1.34B9.84%5.15B10.20%1.35B7.92%1.29B10.26%1.28B11.08%1.22B10.95%4.69B9.01%1.22B7.17%1.2B
Cost of revenue 2.50%544.08M1.47%514.76M3.02%2.09B3.99%527.93M4.19%525.33M2.90%530.81M1.00%507.29M8.71%2.03B0.59%507.67M1.01%504.2M
Gross profit 16.96%878.72M14.44%820.82M15.05%3.05B14.61%820.07M10.63%766.41M16.13%751.28M19.52%717.22M12.72%2.66B15.90%715.53M12.15%692.78M
Operating expense 14.10%381.13M8.66%358.47M7.58%1.37B8.73%363.5M6.90%340.14M8.59%334.03M6.06%329.91M5.61%1.27B0.95%334.31M0.35%318.2M
Selling and administrative expenses 15.22%278.4M8.46%259.19M8.06%991.02M9.47%265.13M6.69%245.3M8.76%241.61M7.23%238.98M4.94%917.14M0.62%242.19M0.64%229.92M
Research and development costs 11.79%90.97M9.81%87.32M7.73%331.28M6.90%86.44M8.91%83.94M10.14%81.37M5.04%79.52M6.91%307.53M3.48%80.86M0.83%77.07M
Depreciation amortization depletion 6.49%11.76M4.84%11.96M-2.68%45.27M5.91%11.93M-2.76%10.9M-4.58%11.05M-8.61%11.4M10.71%46.52M-8.58%11.26M-8.07%11.2M
-Depreciation and amortization 6.49%11.76M4.84%11.96M-2.68%45.27M5.91%11.93M-2.76%10.9M-4.58%11.05M-8.61%11.4M10.71%46.52M-8.58%11.26M-8.07%11.2M
Operating profit 19.26%497.6M19.37%462.35M21.91%1.69B19.77%456.57M13.80%426.27M22.96%417.24M34.02%387.31M20.15%1.38B33.18%381.22M24.58%374.58M
Net non-operating interest income expense 1,125.68%7.95M629.38%8.79M109.00%4.11M197.23%5.76M107.19%793K94.39%-775K88.89%-1.66M3.53%-45.71M60.38%-5.92M26.32%-11.03M
Non-operating interest expense -----------------------------3.53%45.71M--------
Total other finance cost -1,125.68%-7.95M-629.38%-8.79M-109.00%-4.11M-197.23%-5.76M-107.19%-793K-94.39%775K-88.89%1.66M-3.53%45.71M-60.38%5.92M-26.32%11.03M
Other net income (expense) -606.80%-9.4M-1,030.32%-24.35M81.06%-13.94M75.66%-4.28M-178.97%-9.37M102.81%1.85M-16.50%-2.15M-2,392.04%-73.62M-418.92%-17.56M223.15%11.86M
Earnings from equity interest 603.04%1.82M-1,761.13%-4.7M-12.93%-6.66M91.34%-1.27M-136.99%-5.31M68.49%-362K106.29%283K-321.79%-5.89M-283.16%-14.61M130.30%14.36M
Special income (charges) ---5.94M---15.81M96.84%-2.03M---2.03M--0--0--0-63,692.08%-64.23M--0--0
-Less：Restructuring and merger&acquisition --5.94M--15.81M-96.84%2.03M--2.03M--0--0--0219.13%64.23M--0--0
Other non- operating income (expenses) -338.36%-5.28M-57.41%-3.84M-50.43%-5.26M66.89%-979K-62.50%-4.06M423.03%2.22M-192.03%-2.44M38.83%-3.49M-4,947.54%-2.96M2.65%-2.5M
Income before tax 18.60%496.15M16.50%446.79M32.64%1.68B28.04%458.05M11.26%417.69M61.23%418.32M40.89%383.5M14.81%1.26B29.24%357.73M29.73%375.42M
Income tax 40.51%103.56M36.20%98.26M13.53%276.84M19.62%78.35M-29.73%52.65M45.50%73.7M36.71%72.14M19.47%243.85M38.95%65.5M31.74%74.93M
Net income 13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M
Net income continuous Operations 13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M
Minority interest income
Net income attributable to the parent company 13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.92%392.59M11.94%348.54M37.20%1.4B29.93%379.71M21.48%365.04M65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M
Basic earnings per share 14.47%2.6912.26%2.3837.61%9.5530.15%2.5922.06%2.4965.49%2.3542.28%2.1213.40%6.9427.56%1.9929.11%2.04
Diluted earnings per share 14.53%2.6812.32%2.3737.43%9.5130.30%2.5821.57%2.4864.79%2.3441.61%2.1113.63%6.9226.92%1.9829.11%2.04
Dividend per share 13.21%0.613.21%0.610.42%2.1210.42%0.5310.42%0.5310.42%0.5310.42%0.539.09%1.929.09%0.489.09%0.48
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -